An increasing number of people is affected by fungal biofilm-based infections, which are
resistant to the majority of currently-used antifungal drugs. Such infections are often caused …

Highlights•Fungal infections affect an expanding population of immunosuppressed
patients.•The current arsenal of antifungal drugs is exceedingly limited.•Toxicity problems …

Fungal diseases affect a considerable proportion of the worldwide population, ranging in
severity from mild supericial infections to grave invasive diseases [1-7]. he emergence and …

Pathogenic fungi have the capacity to form tenacious biofilm structures that are notoriously
unresponsive to antifungal therapies. Fungal biofilms are ubiquitous, located all over the …

The past decades have witnessed a dramatic increase in invasive fungal infections,
especially caused by different species belonging to the Candida genus. Nowadays, even …

Background Biofilms contribute to the pathogenesis of many chronic and difficult-to
eradicate infections whose treatment is complicated due to the intrinsic resistance to …

Many bacteria grow on surfaces forming biofilms. In this structure, they are well protected
and often high dosages of antibiotics cannot clear infectious biofilms. The formation and …

Bacterial biofilms widely exist in nature and seriously threaten global public health. Biofilms
always cause persistent infection and seriously aggravate the occurrence of antibiotic …

In nature, microorganisms prefer to reside in structured microbial communities, termed
biofilms, rather than as free-floating planktonic cells. Advantageous for the microorganisms …

The human fungal opportunistic pathogen Candida albicans resides in the human gut,
genitourinary tract and on the skin. The majority of infections caused by C. albicans are …